A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/205 (2006.01) A61P 7/08 (2006.01)
Patent
CA 2381187
The method for the treatment of chronic uraemic patients undergoing periodical dialysis is useful for preventing and/or treating carnitine deficiency in patients with end stage renal disease who are undergoing dialysis. The method according to the present invention comprises administering an effective dose of carnitine intravenously into the venous return line after each dialysis session.
L'invention concerne un procédé destiné au traitement des patients souffrant d'urémie chronique soumis à une dialyse périodique. Ce procédé est utilisé pour prévenir et/ou traiter la déficience en carnitine chez des patients souffrant d'une maladie rénale au stade final et soumis à une dialyse. Selon l'invention, ce procédé consiste à administrer une dose efficace de carnitine par intraveineuse dans le tuyau de retour veineux après chaque dialyse.
Fetherstonhaugh & Co.
Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.
LandOfFree
Intravenous carnitine for the treatment of chronic uraemic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intravenous carnitine for the treatment of chronic uraemic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenous carnitine for the treatment of chronic uraemic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1363074